The Brighterside of News on MSN6 小时
New eye drops successfully treat age-related macular degeneration
Toll-like receptors (TLRs) are vital components of the immune system, acting as sentinels that detect and respond to ...
Pharmaceutical Technology10 小时
CBX-12 by Cybrexa for Gallbladder Cancer: Likelihood of Approval
CBX-12 is under clinical development by Cybrexa and currently in Phase II for Gallbladder Cancer. According to GlobalData, Phase II drugs for Gallbladder Cancer have a 32% phase transition success ...
Pharmaceutical Technology10 小时
SCO-240 by Scohia Pharma for Growth Hormone Deficiency: Likelihood of Approval
SCO-240 is under clinical development by Scohia Pharma and currently in Phase I for Growth Hormone Deficiency.